UT M.D. Anderson Cancer Center Lymphoma SPORE

德克萨斯大学安德森癌症中心提出了一项卓越研究淋巴瘤专业项目（SPORE）。淋巴瘤孢子的主要目标是通过创新的治疗策略来提高淋巴瘤的治愈率，这些策略基于淋巴瘤生物学、免疫学和分子遗传学的最新发现。m.d. Anderson淋巴瘤孢子是基础和转化科学家、临床研究者、血液病理学家和生物统计学家之间的多学科合作成果，由4个研究项目和4个核心资源以及发展研究和职业发展计划组成。

The University of Texas M. D. Anderson Cancer Center is proposing a Lymphoma Specialized Program of Research Excellence (SPORE). The primary goal of this Lymphoma SPORE is to improve the cure rate of lymphoma through innovative therapeutic strategies based on effective and focused translation of recent discoveries in lymphoma biology, immunology, and molecular genetics. The M. D. Anderson Lymphoma SPORE is a multidisciplinary collaborative effort between basic and translational scientists, clinical investigators, hematopathologists, and biostatisticians that is organized in 4 research projects and 4 core resources, as well as programs for developmental research and career development program. The research projects listed are designed to target specific areas important in lymphoma: Project 1 - Epigenetic-based therapy of Hodgkin lymphoma (Liu/Younes) Project 2 - Development of 8-chloro-adenosine therapy (Gandhi/McLaughlin) Project 3 - Targeting MDM2/P53 in ALL (Andreeff/O'Brien) Project 4 - Gene expression profiling and pathway targeted therapy in peripheral T-cell lymphoma (Chan/Vose) Core and other resources are the following: Core A - Administrative Core B - Biospecimen Core C - Clinical Research Core D - Biostatistics and Bioinformatics Development Research Program (DRP) and Career Development Program (CDP)